Killer cell immunoglobulin-like receptor expression delineates in situ Sézary syndrome lymphocytes

Journal of Pathology

Volumn 199, Issue 1, 2003, Pages 77-83

  Wechsler, Janine ^a   Bagot, Martine ^a,b   Nikolova, Maria ^b   Parolini, Silvia ^c   Martin Garcia, Nadine ^a   Boumsell, Laurence ^b   Moretta, Alessandro ^d   Bensussan, Armand ^b  

^a HENRI MONDOR HOSPITAL   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c UNIVERSITY OF BRESCIA   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Cutaneous T cell lymphoma; Immunophenotype; KIR3DL2; Mycosis fungoides; S zary syndrome

Indexed keywords

CD30 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; KILLER CELL; LARGE CELL LYMPHOMA; LICHEN PLANUS; LUPUS ERYTHEMATOSUS; LYMPHOCYTIC INFILTRATION; LYMPHOMATOID PAPULOSIS; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SEZARY CELL; SEZARY SYNDROME; T LYMPHOCYTE; TUMOR CLASSIFICATION;

ANTIBODIES, MONOCLONAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LICHEN PLANUS; LYMPHOMA, T-CELL, PERIPHERAL; LYMPHOMATOID PAPULOSIS; MYCOSIS FUNGOIDES; RECEPTORS, IMMUNOLOGIC; SEZARY SYNDROME; SKIN; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0037218883     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1251     Document Type: Article

References (19)

1. Long EO. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 1999; 17: 875-904.
2. Moretta A, Biassoni R, Bottino C, et al. Major histocompatability complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev 1997; 155: 105-117.
3. Lanier LL. NK cell receptors. Annu Rev Immunol 1998; 16: 359-393.
4. Mingari MC, Moretta A, Moretta L. Regulation of KIR expression in human T lymphocytes. A safety mechanism which may impair protective T cell responses. Immunol Today 1998; 19: 153-157.
5. Ugolini S, Arpin C, Anfossi N, et al. Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells. Nat Immun 2001; 2: 430-435.
6. Bagot M, Moretta A, Sivori S, et al. CD4+ cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor. Blood 2001; 97: 1388-1391.
7. Gardiner CM, Guethlein LA, Shilling HG, et al. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J Immunol 2001; 166: 2992-3001.
8. Wood GS, Deneau DG, Miller RA, Levy R, Hoppe PT, Warnke RA. Subtypes of cutaneous T-cell lymphoma defined by expression of Leu-1 and Ia. Blood 1982; 59: 876-882.
9. Laetsch B, Häffner A, Döbbeling U, et al. CD4+/CD7- T cell frequency and polymerase chain reaction-based clonality assay correlate with stage in cutaneous T cell lymphomas. J Invest Dermatol 2000; 114: 107-111.
10. Nikolova M, Tawab A, Marie-Cardine A, Bagot M, Boumsell L, Bensussan A. Increased expression of a novel early activation surface membrane receptor in cutaneous T cell lymphoma cells. J Invest Dermatol 2001; 116: 731-738.
11. Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997; 90: 354-371.
12. Bagot M, Echchakir H, Mami-Chouaib F, et al. Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T cell clones infiltrating a cutaneous T-cell lymphoma. Blood 1998; 91: 4331-4341.
13. Pende D, Biassoni R, Cantoni C, et al. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p7O family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140 kD disulphide-linked dimer. J Exp Med 1996; 184: 505-518.
14. Parolini S, Cantoni C, Castriconi R, et al. The AZ158 MAb specifically reacts with p70 and p140 inhibitory NK receptors for HLA-B and HLA-A alleles. In Leucocyte Typing VII, White Cell Differentiation Antigens Mason D (ed.). Oxford University Press Inc: New York, 2002; 415-417.
15. Poszepczynska E, Bagot M, Echchakir H, et al. Functional characterization of an IL-7-dependent CD4 + CD8 alpha alpha+ Th3-type malignant cell line derived from a patient with a cutaneous T-cell lymphoma. Blood 2000; 96: 1056-1063.
16. Wood GS, Edinger A, Hoppe RT, Warnke RA. Mycosis fungoides skin lesions contain CD8+ tumor-infiltrating lymphocytes expressing an activated, MHC-restricted cytotoxic T-lymphocyte phenotype. J Cutan Pathol 1994; 21: 151-156.
17. Berger CL, Wang N, Christensen I, Longley J, Heald P, Edelson RL. The immune response to class I-associated tumor-specific cutaneous T-cell lymphoma antigens. J Invest Dermatol 1996; 107: 392-397.
18. Vergier B, de Muret A, Beylot-Barry M, et al. Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. Blood 2000; 95: 2212-2218.
19. Boulland ML, Wechsler J, Bagot M, Pulford K, Kanavaros P, Gaulard P. Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins. Histopathology 2000; 36: 136-144.